CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 180 Degree Capital Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

180 Degree Capital Corp
7 N Willow St Ste 4B
Phone: (973) 746-4500p:973 746-4500 MONTCLAIR, NJ  07042-3591  United States Ticker: TURNTURN
Business Summary
180 Degree Capital Corp. is a non-diversified closed-end management investment company. The Company operates as an internally managed investment company. The Company’s investment objective is to generate capital appreciation and current income from investments and investment-related activities such as managed funds and accounts. The Company invests its assets in various industries, including advertising, application software, asset management and custody banks, communications equipment, construction machinery and heavy trucks, electronic manufacturing services, fertilizers and agricultural chemicals, health care equipment, health care technology, interactive media and services, pharmaceuticals, restaurants, specialty chemicals, technology hardware, storage and peripherals, trading companies and distributors, and steel.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
Yes------

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes---

Industries
SIC Code Description
6799 Investors, not elsewhere classified
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Portfolio Manager Kevin M.Rendino 57 1/1/2021 6/1/2016
President, Chief Financial Officer, Chief Compliance Officer, Director, Portfolio Manager Daniel B.Wolfe 47 3/29/2017 7/1/2004
Vice President - Head of Fund Development Robert E.Bigelow 56 10/1/2017 10/1/2017
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ANCORA PHARMACEUTICALS 2B GILL ST WOBURN MA

Business Names
Business Name
Ancora Pharmaceuticals
H&H Ventures Management, Inc.SM Delaware
Harris & Harris Group,Inc
Harris Partners I, L.P.SM
TINY
TURN

General Information
Number of Employees: 7 (As of 12/31/2016)
Outstanding Shares: 10,000,141 (As of 6/30/2024)
Shareholders: 12,500
Stock Exchange: NASD
Federal Tax Id: 133119827
Fax Number: (212) 582-9563
Email Address: matthews@interport.net


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024